MOMA Therapeutics Appoints Semi Trotto as Chief People and Experience Officer
Retrieved on:
Wednesday, September 8, 2021
“MOMA is a truly special company that holds tremendous potential to make a meaningful difference for patients through an entirely new scientific approach. Equally unique are the people who make up MOMA’s DNA -- relentless drug hunters who represent some of the brightest minds in our industry,” said Ms. Trotto. “I am excited and honored to join MOMA at this important inflection point to lend my experience in defining the company’s vibrant culture and growth of the team.”
Key Points:
- MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced that Semi Trotto has been appointed as the companys chief people and experience officer.
- Ms. Trotto brings to MOMA more than 20 years of experience in human resources, with a focus on talent acquisition and management, leading change and transformation, and individual and team coaching and development.
- Prior to MOMA, Ms. Trotto was at Thrive Earlier Detection, where she initially served as chief people officer since the companys inception.
- MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting molecular machines that underlie human disease.